EltaMD AI Visibility Market Strategy Report - Sunscreen Brands

Answer Capsule

EltaMD holds the strongest first-position recommendation signal in the October 2026 Sunscreen Brands benchmark, with a rank-one rate of 31.35% across 622 qualified observations. The brand is visible and well-placed where it appears, but its valid recommendation coverage fell 7.3 points from July 2026 to 73.47%, a third consecutive monthly decline driven by falling presence rather than weaker placement. The clearest win is EltaMD's category-leading rank-one rate and its 0.9914 net sentiment score. The clearest weakness is that AI systems mention EltaMD in fewer answers than they did at baseline. The clearest opportunity is to rebuild presence in the high-intent consideration prompts where the brand has dropped out of AI answers entirely.

Who This Report Is For

This report is written for EltaMD's brand, growth, and ecommerce leadership, and for the dermatologist-recommended skincare marketers who need to understand how AI systems are recommending sunscreen brands at the decision moment.

Report Card

Executive Summary

EltaMD is one of the strongest recommendation-stage brands in the October 2026 Sunscreen Brands benchmark, but it is losing reach. The brand recorded 463 mentions across 622 qualified observations, a raw mention presence rate of 74.44%, and 457 valid recommendations, a valid recommendation coverage of 73.47%. That places EltaMD third in the category behind La Roche-Posay at 92.93% and CeraVe at 76.21%.

The defining feature of EltaMD's position is a split between reach and standing. The brand's top-three rate rose 2.9 points from July 2026 to 53.22%, and its rank-one rate held essentially flat at 31.35%, the highest first-position share of any tracked brand. Where EltaMD appears, AI systems recommend it and place it at or near the top of the shortlist. The problem is that it appears less often.

EltaMD's valid recommendation coverage fell 7.3 points from 80.8% in July 2026 to 73.5% in October 2026, a significant decline and the brand's third consecutive monthly decline. The decline was entirely a presence effect. Raw mention presence fell 12.0 points from 86.4% to 74.4%. Top-three placement strengthened over the same period, which means the brand did not lose standing in the answers where it still appears. It lost access to answers.

Sentiment is not the issue. EltaMD recorded 459 positive mentions, 4 neutral mentions, and zero negative mentions, producing a net sentiment score of 0.9914, the highest in the tracked set. AI systems frame EltaMD positively when they mention it. The gap is coverage, not framing.

The strongest platform signal for EltaMD is Copilot, where the brand holds a rank-one rate of 56.96% and a top-three rate of 79.75%. The weakest platform signal is Perplexity, where EltaMD's valid recommendation coverage is 70.27%, below its category average. Google AI Overviews carries the largest share of EltaMD's recommendation value, which makes that surface the highest-leverage place to rebuild presence.

The clearest gap is in the consideration cluster. All 622 qualified observations in October 2026 fell into the Brand Recommendation class, covering discovery and consideration queries such as which sunscreen is best for acne-prone skin or which sunscreen dermatologists recommend most. EltaMD's decline is concentrated in exactly this prompt type. The brand is being displaced from answers it used to appear in, and the benchmark does not yet measure pricing or head-to-head comparison queries that would show whether EltaMD wins when buyers compare options directly.

One high-severity factual inconsistency was detected for EltaMD across two AI platforms. ChatGPT and Gemini provided conflicting prices for the same EltaMD UV Clear product when asked the same question, which is a trust risk at the exact moment a buyer is forming a shortlist.

What EltaMD Is Winning

Questions This Section Answers

• Where does EltaMD lead the sunscreen category in AI recommendations?
• Which platform gives EltaMD its strongest rank-one and top-three signal?

EltaMD holds the strongest first-position recommendation signal in the category. Its rank-one rate of 31.35% is more than 11 points above CeraVe's 20.10% and more than 12 points above La Roche-Posay's 18.81%, even though both competitors have higher overall recommendation coverage. When AI systems place EltaMD on a shortlist, they place it first more often than any other tracked brand.

EltaMD also holds the highest net sentiment score in the tracked set at 0.9914, with 459 positive mentions, 4 neutral mentions, and zero negative mentions. AI systems do not frame EltaMD cautiously or negatively. The brand's framing quality is the strongest in the category.

EltaMD's top-three rate rose from 50.3% in July 2026 to 53.22% in October 2026, a 2.9 point gain. Its average recommended rank of 2.20 is the best in the category, ahead of La Roche-Posay at 2.31 and CeraVe at 2.58. On placement quality, EltaMD leads.

Copilot is EltaMD's strongest platform. The brand holds a 79.75% top-three rate and a 56.96% rank-one rate there, both far above its category averages. Google AI Overviews is EltaMD's largest single source of recommendation value, and the brand holds a 50.98% top-three rate and a 28.10% rank-one rate on that surface.

Where EltaMD Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Is EltaMD losing AI recommendations because of placement or presence?
• Which competitors have passed EltaMD on recommendation coverage, and on which prompt types is the gap concentrated?
• Where is EltaMD's weakest platform signal?

EltaMD's clearest gap is presence, not placement. The brand's raw mention presence rate fell 12.0 points from 86.4% in July 2026 to 74.4% in October 2026. Over the same period, La Roche-Posay held presence at 95.82% and CeraVe held presence at 79.58%. EltaMD is now mentioned in fewer AI answers than both of its closest competitors, despite placing better than either when it does appear.

The displacement pattern is visible in the coverage numbers. EltaMD's valid recommendation coverage of 73.47% sits 19.5 points behind La Roche-Posay's 92.93% and 2.7 points behind CeraVe's 76.21%. In July 2026, EltaMD led CeraVe on coverage at 80.8% versus 70.4%. By October 2026, CeraVe had passed EltaMD. CeraVe gained 5.8 points of coverage over that span while EltaMD lost 7.3 points.

The gap is concentrated in the consideration cluster, which is the only cluster with qualified observations in this benchmark. Prompts such as which sunscreen is best for acne-prone skin, what is the most recommended sunscreen by dermatologists, and which sunscreen is best for combination skin are the question types where EltaMD has lost ground. These are the prompts where buyers form shortlists.

Perplexity is EltaMD's weakest platform signal. The brand's valid recommendation coverage there is 70.27%, below its category average of 73.47%, and its rank-one rate is 21.62%, well below its category-leading 31.35%. Perplexity also carries the smallest share of EltaMD's recommendation value among the six tracked surfaces.

EltaMD has no measured presence in pricing and value queries or multi-brand comparison queries. The benchmark recorded zero qualified observations in those buyer-intent classes for any brand in October 2026, so this is a measurement gap rather than a confirmed weakness. It does mean the benchmark cannot show whether EltaMD wins or loses when buyers ask AI systems to compare sunscreen options head to head or evaluate price and value.

Biggest Opportunity

Questions This Section Answers

• What is driving EltaMD's declining AI presence if its placement is still strong?
• Which surface should EltaMD prioritize to rebuild AI recommendation presence?

EltaMD's biggest opportunity is to rebuild presence in the high-intent consideration prompts where it has dropped out of AI answers, without changing how it is framed. The brand already converts mentions into top-three placements at a higher rate than any competitor and holds the category's strongest rank-one rate. The mechanism that is failing is retrieval, not recommendation.

The evidence points to a specific path. EltaMD's presence fell 12.0 points while its placement strengthened. That pattern suggests AI systems still recommend EltaMD strongly when they retrieve it, but they are retrieving it less often. The fix is to strengthen the public evidence layer that AI systems draw on for consideration prompts, particularly the source types that appear in the citation data: editorial and beauty media, general news outlets, retail pages, video, and community sources.

The highest-leverage surface is Google AI Overviews, which carries the largest share of EltaMD's recommendation value and where the brand already holds a 50.98% top-three rate. Rebuilding presence there would compound across the largest single source of EltaMD's AI recommendation value. Copilot is the second priority, where EltaMD already holds a 56.96% rank-one rate and has room to extend its lead.

Competitive Landscape

Questions This Section Answers

• How does EltaMD rank against La Roche-Posay and CeraVe on coverage, top-three, and rank-one rates?
• Why does EltaMD place higher than its coverage rank suggests?

La Roche-Posay holds the strongest recommendation-stage position in the Sunscreen Brands category, with CeraVe and EltaMD forming the challenger tier behind it. EltaMD sits third on top-three rate and first on rank-one rate, which means it places higher than its overall coverage rank suggests.

Average recommended rank covers rank-eligible recommendations only.

EltaMD's top-three rate of 53.22% places it second in the category, behind La Roche-Posay and ahead of CeraVe. Its rank-one rate of 31.35% is the highest of any tracked brand, more than 11 points above CeraVe and more than 12 points above La Roche-Posay. Its average recommended rank of 2.20 is the best in the set. The table shows a brand that places at the top of shortlists when it appears, but appears less often than the two brands ahead of it on coverage.

AI Response Inconsistency Alerts

Questions This Section Answers

• What pricing conflict did AI platforms produce for the EltaMD UV Clear product?
• Which prompt type triggered the EltaMD pricing inconsistency, and why does it matter for buyers forming a shortlist?

One critical factual inconsistency was detected for EltaMD across two AI platforms, ChatGPT and Gemini. The conflict concerns the price of the EltaMD UV Clear product and was flagged at high severity with 0.85 confidence.

When asked which is the best sunscreen for acne-prone skin, ChatGPT stated that EltaMD UV Clear costs $25.50, citing the American Academy of Dermatology page on choosing the right sunscreen. Gemini, answering the same question, stated that the same product costs $76.00. The same product cannot cost both amounts. The two platforms produced directly conflicting pricing information in response to an identical high-intent consideration prompt.

The conflict matters because it surfaced on a prompt type where buyers are actively forming a shortlist. A buyer who asks an AI system which sunscreen is best for acne-prone skin and receives a price for EltaMD UV Clear may receive a different price depending on which platform they use. The ChatGPT response cited a dermatology association page as its source, while the Gemini response did not expose a source in the conflict record. The inconsistency is a trust and accuracy risk at the decision moment, and it sits on the same consideration prompt type where EltaMD's presence has been declining.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "Which is the best sunscreen for acne prone skin?" Result: EltaMD appeared in 66.28% of ChatGPT observations with a 45.35% top-three rate and a 29.07% rank-one rate, but the same prompt triggered a pricing conflict between ChatGPT and Gemini on the EltaMD UV Clear product.

Copilot / Brand Recommendation Prompt: "What is the most recommended sunscreen by dermatologists?" Result: EltaMD recorded its strongest platform signal on Copilot, with a 79.75% top-three rate and a 56.96% rank-one rate, the highest first-position share of any brand on any tracked surface.

Google AI Overviews / Brand Recommendation Prompt: "Which sunscreen is best for combination skin?" Result: EltaMD appeared in 74.51% of Google AI Overviews observations with a 50.98% top-three rate and a 28.10% rank-one rate, and this surface carries the largest share of the brand's recommendation value.

Perplexity / Brand Recommendation Prompt: "What is the best sunscreen for Accutane?" Result: EltaMD's weakest platform signal, with a 70.27% valid recommendation coverage and a 21.62% rank-one rate, both below its category averages.

What CiteWorks Studio Would Do Next

Questions This Section Answers

• Which considerations prompts should EltaMD audit first to find where it dropped out of AI answers?
• How should EltaMD strengthen its owned content and citation layer to recover AI presence?

Phase 1: AI Visibility Market Discovery Audit. Map the exact consideration prompts where EltaMD has dropped out of AI answers since July 2026 and identify which competitors absorbed those placements.

Phase 2: Recommendation Readiness Plan. Prioritize the prompt families with the largest presence gap and the highest commercial intent, starting with the acne-prone and dermatologist-recommended question types where EltaMD already places well when retrieved.

Phase 3: Owned Answer Layer Buildout. Strengthen EltaMD's owned pages and product content so AI systems can retrieve accurate, consistent product information, including pricing, for the consideration prompts where the brand is losing presence.

Phase 4: Citation and Authority Layer Development. Build presence in the editorial, beauty media, retail, and community source types that dominate the citation layer behind AI sunscreen recommendations, since no tracked brand's own domain appears in the top 10 cited domains.

Phase 5: Monthly AI Visibility and Recommendation Tracking. Track EltaMD's presence, recommendation coverage, top-three rate, rank-one rate, and sentiment month over month across all six surfaces to confirm whether presence recovers and whether the pricing inconsistency resolves.

Why This Matters

EltaMD is winning the placement battle and losing the presence battle. The brand holds the highest rank-one rate and the best average recommended rank in the category, which means AI systems recommend it first more often than any competitor when they mention it. But the brand is being mentioned in fewer answers than it was in July 2026, and CeraVe has now passed it on overall recommendation coverage.

For a dermatologist-recommended sunscreen brand, presence in AI answers at the consideration stage is the shortlist. A buyer who asks which sunscreen is best for acne-prone skin and does not see EltaMD in the answer cannot choose EltaMD, no matter how strongly the brand would have been recommended if it had appeared. The next move is targeted correction of the prompt, page, and citation layers that determine whether EltaMD is retrieved at all, alongside resolving the pricing inconsistency that surfaced between ChatGPT and Gemini on the same prompt type.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For EltaMD in October 2026, that is (459 × 1 + 4 × 0 + 0 × -1) / 463, which produces a net sentiment score of 0.9914.

This matters because unclassified mention counts are misleading. A brand can appear in hundreds of AI answers and still lose the recommendation if those appearances are neutral references, cautionary notes, or competitor comparisons where the brand is named as an alternative rather than a choice. Counting every mention as a win is bad measurement.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal in commercial value. EltaMD's 0.9914 score means almost every mention is framed positively, with only 4 neutral mentions and no negative mentions across 463 appearances. That is the strongest framing quality in the tracked set. But framing quality alone does not recover presence. EltaMD's sentiment is excellent while its coverage is declining, which is exactly why classified sentiment and coverage must be read together rather than collapsed into a single visibility number.

Sentiment by Platform

Methodology

1. This report is a benchmark-based AI Visibility Company Market Strategy Report for EltaMD in the Sunscreen Brands vertical, produced from the LLM Authority Index AI Visibility Market Discovery Index and supporting metrics aggregation for October 2026.
2. The reporting month is October 2026, with comparison points from July 2026, August 2026, and September 2026 where the benchmark provides them.
3. Six AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode. All six carried at least one qualified observation in October 2026.
4. The October 2026 benchmark began with 800 prompt-surface observations and 653 unique questions, producing 622 qualified observations after qualification. The July 2026 baseline produced 557 qualified observations.
5. The competitor universe contains nine tracked brands: CeraVe, Cetaphil, EltaMD, Kopari Beauty, La Roche-Posay, Neutrogena, Sun Bum, Supergoop, and Vichy.
6. One public high-intent cluster carried qualified observations in October 2026: Best Dermatologist Recommended Skin Care Brands, a consideration-stage cluster. Two additional clusters covering comparison and pricing and value recorded no qualified observations.
7. Stage 0 extraction retained the query, AI or search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources for each observation.
8. A mention is counted when a tracked brand appears in an AI response to a qualified prompt, regardless of whether the brand is recommended.
9. A valid recommendation is counted when the dataset explicitly marks the brand as recommended or shortlisted, separate from a neutral reference, a cautionary mention, or a comparison anchor.
10. Brand-level percentages use the 622 qualified observations as the public denominator, not the 800 raw prompt-surface collections.
11. Average recommended rank covers rank-eligible recommendations only. Brands with no rank-eligible recommendations are shown as N/A.
12. Limitations: the public benchmark does not measure market share or sales attribution, every possible AI response to a given query, organic-search ranking performance, social media mention volume, private or sponsored AI channels, or causality from a metric movement alone. The benchmark recorded no qualified observations for pricing and value or multi-brand comparison queries in October 2026, so price sensitivity and head-to-head comparison cannot be assessed from this data. The pricing inconsistency between ChatGPT and Gemini surfaced through dedicated conflict detection and is not part of the qualified recommendation set.

See How AI Is Recommending Your Brand

The public benchmark shows where EltaMD stands in AI recommendations across the Sunscreen Brands category. A company-level AI visibility audit maps the specific prompts, surfaces, competitors, and source pages behind these numbers, including the consideration prompts where EltaMD has lost presence and the pricing inconsistency that surfaced between ChatGPT and Gemini. That analysis turns the standings in this report into a prioritized plan for rebuilding presence without losing the placement strength EltaMD already holds.